![David Scott Saperstein](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Scott Saperstein
Präsident bei Phoenix Neurological Associates Ltd.
Ursprung des Netzwerks ersten Grades von David Scott Saperstein
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Phoenix Neurological Associates Ltd.
![]() Phoenix Neurological Associates Ltd. Medical/Nursing ServicesHealth Services Phoenix Neurological Associates Ltd. engages in treating patients with neurologic diseases. It specializes in alzheimers, amyotrophic lateral sclerosis, chronic inflammatory demyelinating polyneuropathy, dermatomyositis, epilepsy, guillain barre syndrome, headache, inclusion body myositis, movement disorders, multiple sclerosis and muscular dystrophy. The company is headquartered in Phoenix, AZ.
3
| Private Company | Medical/Nursing Services | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von David Scott Saperstein
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Banner–University Medical Center Phoenix
![]() Banner–University Medical Center Phoenix Medical/Nursing ServicesHealth Services Banner–University Medical Center Phoenix provides medical care, treatment and recovery services. It offers emergency, family healthcare, laboratory, wellness, and maternity. The company is headquartered in Phoenix, AZ. | Medical/Nursing Services | Corporate Officer/Principal | |
Cnd Life Sciences, Inc.
![]() Cnd Life Sciences, Inc. Medical/Nursing ServicesHealth Services Cnd Life Sciences, Inc. is a company based in an undisclosed location that aims to transform the diagnosis and treatment of neurodegenerative diseases. The company is based in Scottsdale, AZ. The company operates a CLIA-certified and CAP-accredited laboratory and has launched the Syn-One test, the world's first commercially available test that detects and visualizes phosphorylated alpha-synuclein in cutaneous nerves with high accuracy to aid the diagnosis of Parkinson's disease and related disorders. Cnd Life Sciences has scientific collaborations with biopharmaceutical companies and has been awarded three NIH SBIR grants to advance the clinical utility of the Syn-One test. The company allows clinicians to access objective pathological insights on diseases that are often difficult to diagnose and apply those insights to generate better outcomes for patients. The company was founded in 2017 by Todd Dylan Levine, Christopher Gibbons, Roy Freeman, and the CEO is Richard J. Morello. | Medical/Nursing Services | Founder |
Statistik
International
Vereinigte Staaten | 3 |
Sektoral
Health Services | 3 |
Operativ
Director/Board Member | 4 |
Corporate Officer/Principal | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Todd Levine | 3 |
Harry S. Tamm | 1 |
Lori Hendin Travis | 1 |
- Börse
- Insiders
- David Scott Saperstein
- Unternehmensverbindungen